BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10618713)

  • 1. Inhibition of v-Abl transformation by p53 and p19ARF.
    Cong F; Zou X; Hinrichs K; Calame K; Goff SP
    Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
    Guo F; Zheng Y
    Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
    Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA
    Nature; 2001 Sep; 413(6851):86-91. PubMed ID: 11544531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts.
    Suzuki J; Sukezane T; Akagi T; Georgescu MM; Ohtani M; Inoue H; Jat PS; Goff SP; Hanafusa H; Shishido T
    Oncogene; 2004 Nov; 23(52):8527-34. PubMed ID: 15378021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
    Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
    Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
    Goga A; Liu X; Hambuch TM; Senechal K; Major E; Berk AJ; Witte ON; Sawyers CL
    Oncogene; 1995 Aug; 11(4):791-9. PubMed ID: 7651743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts.
    Coutts M; Zou X; Calame K
    Oncogene; 2000 Feb; 19(6):801-9. PubMed ID: 10698498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
    Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
    J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS; Wiman KG
    Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
    Tomicic MT; Christmann M; Kaina B
    Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
    Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming pathways activated by the v-Abl tyrosine kinase.
    Shore SK; Tantravahi RV; Reddy EP
    Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus.
    Noronha EJ; Sterling KH; Calame KL
    J Biol Chem; 2003 Dec; 278(51):50915-22. PubMed ID: 14559912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.